Andrew John Partridge - Jul 14, 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
EVP & Chief Commercial Officer
Signature
/s/ Annette North, Attorney-in-Fact
Stock symbol
TPTX
Transactions as of
Jul 14, 2021
Transactions value $
-$139,988
Form type
4
Date filed
7/15/2021, 05:53 PM
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Sale -$140K -1.87K -7.91% $74.90 21.8K Jul 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares of common stock to cover tax withholding obligations associated with vesting of a restricted stock unit award granted to Reporting Person on July 13, 2020.